JC
JBF Capital Portfolio holdings
AUM
$704M
1-Year Est. Return
25.33%
1 Year Est. Return
+25.33%
AUM
$704M
AUM Growth
+$77.9M
(+12%)
Holding
87
Top Buys
| 1 | +$18.7M | |
| 2 | +$7.34M | |
| 3 | +$3.58M | |
| 4 |
THTX
Theratechnologies
THTX
|
+$2.88M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.5M |
Top Sells
| 1 | +$5.33M | |
| 2 | +$4.85M | |
| 3 | +$686K | |
| 4 |
VIGL
Vigil Neuroscience
VIGL
|
+$557K |
| 5 |
Inhibrx
INBX
|
+$299K |
Sector Composition
| 1 | Technology | 17.58% |
| 2 | Consumer Discretionary | 15.47% |
| 3 | Communication Services | 7.99% |
| 4 | Financials | 3.92% |
| 5 | Healthcare | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRD
76
DELISTED
Third Harmonic Bio
THRD
| $7.5K | ﹤0.01% |
+250,000
|
|
||
|
AKYA
77
DELISTED
Akoya BioSciences
AKYA
| – | – |
-119,508
|
|
||
78
Biohaven
BHVN
$1.59B
| – | – |
-13,150
|
|
||
79
HP
HPQ
$19.1B
| – | – |
0
|
|
||
80
iShares Bitcoin Trust
IBIT
$75.1B
| – | – |
-87,000
|
|
||
|
ICAD
81
DELISTED
iCAD Inc
ICAD
| – | – |
-180,000
|
|
||
|
82
Inhibrx
INBX
$1.07B
| – | – |
-20,949
|
|
||
83
SPDR S&P 500 ETF Trust
SPY
$717B
| – | – |
0
|
|
||
84
Tesla
TSLA
$1.48T
| – | – |
0
|
|
||
|
VIGL
85
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-70,000
|
|
||
86
Vistra
VST
$61.6B
| – | – |
-25,000
|
|
||
|
SBT
87
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| – | – |
-32,064
|
|